2008論文

1	Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Graciano ML, Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto-Carrasquero M, Kobori H and Navar LG. Am. J. Physiol. Renal Physiology. 294: F161-F169, 2008.
2	Do vasculature reactive oxygen species play a role in the mobilization of bone marrow endothelial progenitor cells? Kiyomoto H and Nishiyama A. J. Hypertens. 26: 188-190, 2008.
3	Dietary sesamin suppresses the aortic NADPH oxidase in DOCA-salt hypertensive rat. Nakano D, Kurumazuka D, Nagai Y, Nishiyama A, Kiso Y and Matsumura Y. Clin. Exp. Pharmacol. Physiol. 35: 324-326, 2008.
4	Possible involvement of Rho-kinase in aldosterone-induced vascular remodeling. Miyata K, Sun G-P, Guo P, Hitomi H, Kimura S, Kiyomoto H, Hosomi N, Kohno M and Nishiyama A. Hypertens. Res. 31: 1407-1413, 2008.
5	Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, Morikawa T, Okumura M, Maeda I, Kiyomoto H, Hosomi N, Mori T, Ito S and Imanishi M. J. Hypertens. 26: 1849-1859, 2008.
6	The efficacy of gene therapy for TGF-b in progressive diabetic nephropathy. Nakano D, Kiyomoto H and Nishiyama A. Clin. Exp. Pharmacol. Physiol. 35: 1275-1276, 2008.
7	Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: Effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan. Konishi Y, Morikawa T, Okada N, Maeda I, Kitabayashi C, Yoshioka K, Okumura M, Nishiyama A, Ueda M, Takai S, Miyazaki M and Imanishi M. Hypertens. Res. 31: 1517-1524, 2008.
8	A new approach for selective rat endolymphatic sac epithelium collection to obtain pure specific RNA. Akiyama K, Miyashita T, Matsubara A, Mori T, Inamoto R, Nishiyama A and Mori N. Biochem. Biophys. Res. Commun. 376: 611-614, 2008.
9	Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. Kiyomoto H, Rafiq K, Mostofa M and Nishiyama A. J. Pharmacol. Sci. 108: 399-405, 2008.
10	Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through Rho-kinase dependent signaling pathway in rat mesangial cells. Diah S, Zhang G-X, Hitomi H, Nagai Y, Zhang W, Gang L, Kimura S, Hamid MRWA, Tamiya T and Nishiyama A. Exp Cell Res. 314: 3654-3662, 2008.
11	Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Nakano D, Pollock JS and Pollock DM. Am. J. Physiol. Renal Physiology. 294: F1205-F1211, 2008.
13	Mineralocorticoid receptor blocker. Akira Nishiyama, Hirofumi Hitomi and Hideyasu Kiyomoto. Nippon yakurigaku zasshi. Folia pharmacologica Japonica 132: 244-246, 2008.
14	Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice. Atsuhiro Ichihara, Mariyo Sakoda, Asako Kurauchi-Mito, Akira Nishiyama and Hiroshi Itoh. Journal of the American Society of Hypertension 2(5): 332-340, 2008.
15	Effects of renin inhibition on activated prorenin in human podocytes. M. Sakoda, A. Ichihara, A. Mito-Kurauchi, A. Nishiyama, H. Iwata, T. Nakagawa, F. Suzuki, Y. Kaneshiro, M. A. Saleen and H. Itoh. Journal of Hypertension 26: S199, 2008.
16	A GLP-1 analog, exendin-4, attenuates the developments of renal injury and hypertension in type 2 diabetic db/db mice. Shinji Kume, Kunio Hirata, Shin-Ichi Araki, Akira Nishiyama, Toshiro Sugimoto, Daisuke Koya, Masa-Kazu Haneda, Takashi Uzu, Atsunori Kashiwagi. Diabetes 57: A205-A206, 2008.
17	Chymase inhibitor prevented diabetic nephropathy via attenuation of oxidative stress and NAD(P)H oxidase expression in diabetic hamsters. Yasutaka Maeda, Toyoshi Inoguchi, Shuji Sasaki, Masakazu Fujii, Kunihisa Kobayashi, Hidenori Urata, Akira Nishiyama and Ryoichi Takayanagi. Diabetes 57: A209-A209, 2008.